|
MechanismSARS-CoV-2 Mpro inhibitors |
|
|
|
|
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Into Oregon State University Inc
0 Patents (Medical) associated with Into Oregon State University Inc
100 Deals associated with Into Oregon State University Inc
100 Translational Medicine associated with Into Oregon State University Inc